haz+click+aquí.

__Bibliografía __

Ayra M, Díaz O. Productos de la glucosilación avanzada y diabetes mellitus. Rev Cubana End 1999; 10 (1): 57-64. Trabajos de revisión Instituto Nacional de Endocrinología. http://es.scribd.com/doc/55863203/Productos-de-La-Glucosilaci-n-Avanzada-y-Diabetes-Mellitus

__Referencias __


 * 1) Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications.
 * 2) Beisswenger P, Moore L, Curphy T. Relation of glycemic control collagen-linked advanced glycation end products in type I diabetes.
 * 3) Gagliardino J, Rebolledo O. Glucosilación no enzimática de proteínas y complicaciones crónicas de la diabetes.
 * 4) Mott J, Khalifah R, Nagase H, Shield C, Hudson J, Hudson B. Nonenzymatic glycation of type IV collagen and matrix metalloproteinase susceptibility.
 * 5) Kapurtniotu A, Bernhagen J, Greenfield N, Al-Abed Y, Teichberg S, Frank R. Contribution of advanced glycosilation to the amyloidogenicity of islet amyloid polypeptide.
 * 6) Bucala R, Makita Z, Koschinsky T, Cerami A, Vlassara H. Lipid advanced glycosylation.
 * 7) Krantz S, Michalke R, Brandt R, Salazar R, Hartmann K. Evidence for binding of in vitro glycated low-density lipoproteins by fructosillysine-specific sites on macrophages and U937 monocytes-like cells.
 * 8) Bucala R, Makita Z, Vega G. Modification oj LDL by advanced glycosylation products contributes to the dyslipidemia of diabetes and renal insuficiency.
 * 9) Vlassara H. Advanced glycation end products and atherosclerosis.
 * 10) Miyata T, Ueda Y, Horie K, Nangaku M, Tanaka S, Van Yperselle C. Renal catabolism of advanced glycation end products: the fate of pentosidine.
 * 11) Lefer A, Lefer D. The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusion.
 * 12) Picard S, Parathasarathy S, Fruebis J, Witzim JL. Aminoguanidine inhibits oxidative modification of low density lipoprotein and the subsequent increase in uptake by macrophage scavenger receptors.
 * 13) <span style="color: black; font-family: 'Century Gothic',sans-serif; font-size: 120%;">Traverso N, Menini S, Cottalasso D, Odetti P, Marinari U, Adelaide-Pronzato M. Mutual interaction between glycation and oxidation during non-enzymatic protein modification.
 * 14) <span style="color: black; font-family: 'Century Gothic',sans-serif; font-size: 120%;">Korchinski T, Jiang He C, Mitsuahashi T, Bucala R, Liu C, Bueting C, Heimann K, Vlassara H. Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy.
 * 15) <span style="color: black; font-family: 'Century Gothic',sans-serif; font-size: 120%;">Cerami C, Found H, Nicholl I, Mitsuhashi T, Giordano D, Vanpatten S, et al. Tobacco smoke is a source of toxic reactive glycation products.